META'S DINOV2 FOR CANCER RESEARCH

Summary from the TLDR AI newsletter

Orakl Oncology uses Meta's DINOv2 model to accelerate cancer drug discovery, improving efficiency by quickly analyzing organoid images to predict patient treatment responses.